505 related articles for article (PubMed ID: 31233624)
1. SATB2 in neuroendocrine neoplasms: strong expression is restricted to well-differentiated tumours of lower gastrointestinal tract origin and is most frequent in Merkel cell carcinoma among poorly differentiated carcinomas.
Bellizzi AM
Histopathology; 2020 Jan; 76(2):251-264. PubMed ID: 31233624
[TBL] [Abstract][Full Text] [Related]
2. Clusterin in Neuroendocrine Epithelial Neoplasms: Absence of Expression in a Well-differentiated Tumor Suggests a Jejunoileal Origin.
Czeczok TW; Stashek KM; Maxwell JE; O'Dorisio TM; Howe JR; Hornick JL; Bellizzi AM
Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):94-100. PubMed ID: 29420353
[TBL] [Abstract][Full Text] [Related]
3. Positivity for SATB2 distinguishes Islet1 positive rectal neuroendocrine tumours from pancreaticoduodenal neuroendocrine tumours.
Mohanty SK; Tiwari A; Bhardwaj N; Chuang F; Kim E; Lugo H; Yuan X; Diffalha SA; Peralta-Venturina M; Balzer B; Dhall D
J Clin Pathol; 2021 Sep; 74(9):582-588. PubMed ID: 32934105
[TBL] [Abstract][Full Text] [Related]
4. SATB2 protein expression by immunohistochemistry is a sensitive and specific marker of appendiceal and rectosigmoid well differentiated neuroendocrine tumours.
Hoskoppal D; Epstein JI; Gown AM; Arnold Egloff SA; Gordetsky JB; Shi CJ; Giannico GA
Histopathology; 2020 Mar; 76(4):550-559. PubMed ID: 31595536
[TBL] [Abstract][Full Text] [Related]
5. SATB2 is expressed in neuroendocrine carcinoma of the uterine cervix.
Inzani F; Angelico G; Santoro A; Travaglino A; Insabato L; Raffone A; Arciuolo D; Scaglione G; D'Alessandris N; Valente M; Carlino A; Rindi G; Zannoni GF
Virchows Arch; 2022 Apr; 480(4):873-877. PubMed ID: 35091815
[TBL] [Abstract][Full Text] [Related]
6. Value of SATB2, ISL1, and TTF1 to differentiate rectal from other gastrointestinal and lung well-differentiated neuroendocrine tumors.
Zhao LH; Chen C; Mao CY; Xiao H; Fu P; Xiao HL; Wang G
Pathol Res Pract; 2019 Jul; 215(7):152448. PubMed ID: 31133441
[TBL] [Abstract][Full Text] [Related]
7. Immunoreactivity of HOXB13 in Neuroendocrine Neoplasms Is a Sensitive and Specific Marker of Rectal Well-Differentiated Neuroendocrine Tumors.
Soukup J; Manethova M; Stejskal V; Hornychova H; Cesak T; Netuka D; Ryska A; Gabalec F
Endocr Pathol; 2023 Sep; 34(3):333-341. PubMed ID: 37552455
[TBL] [Abstract][Full Text] [Related]
8. SATB2 is expressed in Merkel cell carcinoma.
Fukuhara M; Agnarsdóttir M; Edqvist PH; Coter A; Ponten F
Arch Dermatol Res; 2016 Aug; 308(6):449-54. PubMed ID: 27262585
[TBL] [Abstract][Full Text] [Related]
9. An algorithmic approach utilizing CK7, TTF1, beta-catenin, CDX2, and SSTR2A can help differentiate between gastrointestinal and pulmonary neuroendocrine carcinomas.
Yu S; Hornick JL; Gonzalez RS
Virchows Arch; 2021 Sep; 479(3):481-491. PubMed ID: 33733343
[TBL] [Abstract][Full Text] [Related]
10. Primary Ovarian High-grade Neuroendocrine Carcinoma With Merkel Cell-like Immunophenotype Arising in a Teratoma.
Harkness R; Kelly PJ; McCluggage WG
Int J Gynecol Pathol; 2020 Sep; 39(5):478-484. PubMed ID: 31584482
[TBL] [Abstract][Full Text] [Related]
11. SATB2 is a sensitive marker for lower gastrointestinal well-differentiated neuroendocrine tumors.
Li Z; Yuan J; Wei L; Zhou L; Mei K; Yue J; Gao H; Zhang M; Jia L; Kang Q; Huang X; Cao D
Int J Clin Exp Pathol; 2015; 8(6):7072-82. PubMed ID: 26261600
[TBL] [Abstract][Full Text] [Related]
12. SATB2 Is Superior to CDX2 in Distinguishing Signet Ring Cell Carcinoma of the Upper Gastrointestinal Tract and Lower Gastrointestinal Tract.
Ma C; Lowenthal BM; Pai RK
Am J Surg Pathol; 2018 Dec; 42(12):1715-1722. PubMed ID: 30212392
[TBL] [Abstract][Full Text] [Related]
13. Pitx2 is a useful marker of midgut-derived neuroendocrine tumours - an immunohistochemical study of 224 cases.
Soukup J; Manethova M; Faistova H; Krbal L; Vitovcova B; Hornychova H; Drugda J; Cesak T; Netuka D; Gabalec F; Ryska A
Histopathology; 2022 Dec; 81(6):799-807. PubMed ID: 36089904
[TBL] [Abstract][Full Text] [Related]
14. SATB2, CKAE1/AE3, and synaptophysin as a sensitive immunohistochemical panel for the detection of lymph node metastases of Merkel cell carcinoma.
Szumera-Cieckiewicz A; Massi D; Cassisa A; Krzyzinski M; Dudzisz-Sledz M; Biecek P; Rutkowski P; Marszalek A; Hoang MP; Donizy P
Virchows Arch; 2024 Apr; 484(4):629-636. PubMed ID: 38066198
[TBL] [Abstract][Full Text] [Related]
15. Expression of SATB2 in Neuroendocrine Carcinomas of the Lung: Frequent Immunopositivity of Large Cell Neuroendocrine Carcinoma with a Diagnostic Pitfall.
Inoue H; Matsushima J; Kobayashi S; Sairenchi T; Hirata H; Chida M; Ota S; Ban S; Matsumura Y
Int J Surg Pathol; 2022 Apr; 30(2):151-159. PubMed ID: 34913369
[TBL] [Abstract][Full Text] [Related]
16. Loss of SATB2 Expression in Colorectal Carcinoma Is Associated With DNA Mismatch Repair Protein Deficiency and BRAF Mutation.
Ma C; Olevian DC; Lowenthal BM; Jayachandran P; Kozak MM; Chang DT; Pai RK
Am J Surg Pathol; 2018 Oct; 42(10):1409-1417. PubMed ID: 30001238
[TBL] [Abstract][Full Text] [Related]
17. Examination of PHOX2B in adult neuroendocrine neoplasms reveals relatively frequent expression in phaeochromocytomas and paragangliomas.
Lee JP; Hung YP; O'Dorisio TM; Howe JR; Hornick JL; Bellizzi AM
Histopathology; 2017 Oct; 71(4):503-510. PubMed ID: 28464318
[TBL] [Abstract][Full Text] [Related]
18. Transcription Factor Expression in Sinonasal Neuroendocrine Neoplasms and Olfactory Neuroblastoma (ONB): Hyams' Grades 1-3 ONBs Expand the Spectrum of SATB2 and GATA3-Positive Neoplasms.
Uccella S; Facco C; Chiaravalli AM; Pettenon F; La Rosa S; Turri-Zanoni M; Castelnuovo P; Cerati M; Sessa F
Endocr Pathol; 2022 Jun; 33(2):264-273. PubMed ID: 35522392
[TBL] [Abstract][Full Text] [Related]
19. Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites.
Kaufmann O; Dietel M
Histopathology; 2000 May; 36(5):415-20. PubMed ID: 10792482
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical characterization of appendiceal mucinous neoplasms and the value of special AT-rich sequence-binding protein 2 in their distinction from primary ovarian mucinous tumours.
Strickland S; Parra-Herran C
Histopathology; 2016 Jun; 68(7):977-87. PubMed ID: 26542609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]